Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024

Rhea-AI Summary

Lucid Diagnostics (Nasdaq: LUCD), a commercial-stage cancer prevention medical diagnostics company, has announced a business update conference call and webcast scheduled for August 12, 2024, at 8:30 AM ET. The event will feature:

• A business update and overview of operations by CEO Lishan Aklog, M.D.
• Discussion of the company's growth strategy
• Presentation of Q2 2024 financial results by CFO Dennis McGrath

Interested parties can access the webcast via the investor relations section of luciddx.com. For telephone access, U.S. callers should dial 1-800-836-8184, while international listeners should use 1-646-357-8785. The conference call name is "Lucid Diagnostics Business Update". A 30-day replay will be available on the company's website after the call.

News Market Reaction – LUCD

-3.33%

1 alert

-3.33% News Effect

On the day this news was published, LUCD declined 3.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast at 8:30AM Eastern Time

NEW YORK, July 29, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Monday, August 12, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update, including an overview of the Company's operations and continued growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's second quarter 2024 financial results.

The webcast will be available at the investor relations section of the Company's website at luciddx.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at luciddx.com.

About Lucid Diagnostics

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-august-12-2024-302207802.html

SOURCE Lucid Diagnostics

FAQ

When is Lucid Diagnostics (LUCD) holding its business update conference call?

Lucid Diagnostics (LUCD) is holding its business update conference call on August 12, 2024, at 8:30 AM Eastern Time.

How can investors access Lucid Diagnostics' (LUCD) Q2 2024 financial results?

Investors can access Lucid Diagnostics' (LUCD) Q2 2024 financial results during the business update conference call on August 12, 2024, where CFO Dennis McGrath will discuss the results.

What topics will be covered in Lucid Diagnostics' (LUCD) August 12 conference call?

The conference call will cover a business update, an overview of operations, the company's growth strategy, and Q2 2024 financial results for Lucid Diagnostics (LUCD).

How can investors join Lucid Diagnostics' (LUCD) August 12 conference call?

Investors can join via webcast at luciddx.com's investor relations section, or by phone: U.S. callers dial 1-800-836-8184, international callers dial 1-646-357-8785, using the name 'Lucid Diagnostics Business Update'.